Colostrinin vs Noopept
A neutral, side-by-side comparison of two nootropic & cognitive peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
Colostrinin
Proline-rich polypeptide complex isolated from ovine (sheep) colostrum. Originally researched as an Alzheimer's disease modulator, colostrinin has shown ability to stabilize cognitive function and reduce progression in mild-to-moderate Alzheimer's patients in double-blind trials. Also studied for immune modulation and anti-aging properties via cytokine balance normalization.
Full profileNoopept
Dipeptide-derived nootropic developed in Russia and used across Eastern Europe as a cognitive enhancer and neuroprotective agent. Structurally related to piracetam but estimated to be approximately 1000× more potent by weight. Rapidly crosses the blood-brain barrier and is hydrolyzed to the endogenous neuropeptide cycloprolylglycine, which is proposed as its primary active metabolite.
Full profile| Colostrinin | Noopept | |
|---|---|---|
| Category | Nootropic & Cognitive | Nootropic & Cognitive |
| Also known as | PRP (proline-rich polypeptide), ND, colostrum neuropeptide, CLN, ovine proline-rich polypeptide | GVS-111, N-phenylacetyl-L-prolylglycine ethyl ester, omberacetam, N-Phenylacetyl-L-Prolylglycine Ethyl Ester |
| Evidence | Research-stage | Research-stage |
| Dosing range | 100mcg–400mcg mcg, sublingual, on a 3 days on / 3 days off cycle | 5mg–20mg mg, 1–3x daily oral or sublingual (8–12 week cycles) |
| Administration | Sublingual tablet/drop | Oral (capsule/powder), Sublingual (dissolved under tongue), Intranasal |
| Key side effects | Generally well-tolerated, Mild GI discomfort, Rare hypersensitivity (relevant for dairy protein sensitivity), Mild fatigue (initial days) | Headache (especially without choline supplementation), Irritability, Brain fog at high doses, Insomnia (if taken too late in day) |
| Cited sources | 2 references | 2 references |
Key differences
- Administration: Colostrinin — Sublingual tablet/drop; Noopept — Oral (capsule/powder), Sublingual (dissolved under tongue), Intranasal.
- Dosing units differ: Colostrinin is dosed in mcg, Noopept in mg — they operate at different scales.
- Frequency: Colostrinin is typically sublingual, on a 3 days on / 3 days off cycle; Noopept is 1–3x daily oral or sublingual (8–12 week cycles).
How each works
Colostrinin
Colostrinin modulates dendritic cell maturation and shifts cytokine balance toward anti-inflammatory patterns (reduced IL-6, TNF-α; increased IL-10). In neurological models, it reduces amyloid-β aggregation, decreases oxidative stress, and upregulates NGF while modulating the HPA axis stress response. A Polish double-blind trial showed statistically significant cognitive stabilization in mild-to-moderate AD patients over 15 weeks.
Noopept
Noopept (GVS-111) enhances AMPA-receptor function and increases expression of BDNF and NGF in the hippocampus and basal forebrain. Its active metabolite cycloprolylglycine acts as an endogenous neuropeptide with anxiolytic and cognition-enhancing properties. Russian clinical trials demonstrate cognitive improvement in subjects with cognitive impairment, with a better tolerability profile than piracetam at equipotent doses.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.